Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Cash & Current Investments came in at $64.3 million in Q1 2026, up 62.32% year-on-year from $39.6 million in Q1 2025, and up 58.63% on a QoQ basis from $40.5 million in Q4 2025.
Senseonics Holdings (SENS) Cash & Current Investments (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Cash & Current Investments data on file, last reported at $64.3 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 62.32% year-over-year to $64.3 million in Q1 2026; TTM through Mar 2026 was $64.3 million, a 62.32% increase from a year earlier, with the FY2025 full-year figure at $40.5 million, down 45.87% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $64.3 million, up from $40.5 million in the prior quarter.
- Over the last five years, Cash & Current Investments for SENS reached as high as $281.7 million in Q3 2022 and fell as low as $39.6 million in Q1 2025.
- Historically, Cash & Current Investments has averaged $134.2 million across 5 years, with a median of $111.0 million in 2025.
- Across the five-year window, Cash & Current Investments jumped 1547.1% in 2022 and tumbled 61.81% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $109.4 million in 2022, then increased by 0.09% to $109.5 million in 2023, then slumped by 31.56% to $74.9 million in 2024, then plunged by 45.87% to $40.5 million in 2025, then soared by 58.63% to $64.3 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $64.3 million in Q1 2026, $40.5 million in Q4 2025, and $111.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Senseonics Holdings | 229.80 Mn | 165.48 Mn | 6.94 Mn | 64.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.32 Mn |
| Dec 31, 2025 | 40.55 Mn |
| Sep 30, 2025 | 110.95 Mn |
| Jun 30, 2025 | 126.72 Mn |
| Mar 31, 2025 | 39.63 Mn |
| Dec 31, 2024 | 74.91 Mn |
| Sep 30, 2024 | 74.48 Mn |
| Jun 30, 2024 | 134.37 Mn |
| Mar 31, 2024 | 99.02 Mn |
| Dec 31, 2023 | 109.46 Mn |
| Sep 30, 2023 | 195.05 Mn |
| Jun 30, 2023 | 214.17 Mn |
| Mar 31, 2023 | 219.96 Mn |
| Dec 31, 2022 | 109.36 Mn |
| Sep 30, 2022 | 281.72 Mn |
| Jun 30, 2022 | 244.26 Mn |
| Mar 31, 2022 | 141.77 Mn |
| Dec 31, 2021 | 100.71 Mn |
| Sep 30, 2021 | 142.78 Mn |
| Jun 30, 2021 | 163.09 Mn |